Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes
Adult
Male
Science
Q
R
Middle Aged
3. Good health
03 medical and health sciences
0302 clinical medicine
Diabetes Mellitus, Type 2
Risk Factors
Prevalence
Medicine
Albuminuria
Humans
Kidney Failure, Chronic
Female
Research Article
Aged
Follow-Up Studies
Glomerular Filtration Rate
DOI:
10.1371/journal.pone.0201535
Publication Date:
2018-08-02T14:31:05Z
AUTHORS (21)
ABSTRACT
According to studies by the National Kidney Foundation and Food Drug Administration, 30% 40% declines in estimated glomerular filtration rate (eGFR) could be used as surrogate endpoints of end-stage renal disease (ESRD). However, benefits using these diabetic patients remain unclear.This cohort study comprised Japanese with type 2 diabetes; those repeated serum creatinine measurements during a baseline period years (n = 1868) or 3 2001) were enrolled. Subsequent risks ESRD following eGFR assessed.In 2-year analysis, cumulative prevalence -20%, -30%, -40%, -53% changes 23.9%, 11.1%, 6.8%, 3.7%, respectively. There 133 cases (7.1%) subsequent median follow-up 6.5 years. In 3-year corresponding proportions 28.1%, 14.0%, 7.7%, 3.9%, respectively, 110 participants (5.5%) reaching 5.5 The adjusted hazard ratios -53%, -20% 22.9 (11.1-47.3), 12.8 (6.9-23.7), 8.2 (4.3-15.5), 3.9 (2.2-7.0), respectively when compared no eGFR. 29.7 (10.8-81.9), 18.4 (7.6-44.7), (5.2-32.2), 5.4 (2.3-12.8), subgroup similar trends observed macroalbuminuria at baseline.Declines strongly associated risk patients. addition declines, 20% decline over considered candidate endpoint kidney disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....